Cargando…
Pan-Cancer Analysis, Reveals COVID-19-Related BSG as a Novel Marker for Treatment and Identification of Multiple Human Cancers
Background: Coronavirus disease 2019 (COVID-19) has been a public threat and healthcare concern caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. During the period of the pandemic of COVID-19, cancer patients should be paid more attention as more severe events are fou...
Autores principales: | Huang, Tao, He, Wei-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136262/ https://www.ncbi.nlm.nih.gov/pubmed/35646943 http://dx.doi.org/10.3389/fcell.2022.876180 |
Ejemplares similares
-
Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines
por: Ding, ShiJian, et al.
Publicado: (2021) -
Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis
por: Zhang, Chiyuan, et al.
Publicado: (2021) -
SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes
por: Kalejaiye, Titilola D., et al.
Publicado: (2022) -
Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis
por: Liu, Ting-Ting, et al.
Publicado: (2021) -
The LIM Protein AJUBA is a Potential Oncogenic Target and Prognostic Marker in Human Cancer via Pan-Cancer Analysis
por: Song, Na, et al.
Publicado: (2022)